Associated Papers
Mutations in CREBBP and EP300 HAT and Bromo Domains Drive Hypermutation and Predict Survival in GI Cancers Treated with Immunotherapy.
Gusakova M et al.
Biomedicines, 2025
41301688 (PubMed )
Supplement: biomedicines-13-02592-s001.zip › Supplementary_Table_S7.xlsx › ____1
A microglia clonal inflammatory disorder in Alzheimer's disease.
Vicario R et al.
Elife, 2025
40085681 (PubMed )
Supplement: elife-96519-supp3.xlsx › ALL-SNV
TP53 Variant in the Blood of a Patient with Gastric Cancer Undergoing Tumor Profiling Tests Diagnosed as Clonal Hematopoiesis.
Kawai M et al.
The American Journal of Case Reports, 2022
Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F study.
Aoyagi Y et al.
Plos One, 2022
35358259 (PubMed )
Supplement: pone.0266112.s001.xlsx › Patients
Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma.
Nie M et al.
Cell Death & Disease, 2021
33911074 (PubMed )
Supplement: 41419_2021_3695_MOESM12_ESM.xlsx › S5._CREBBBP_and_EP300_mutations
Select a paper to view details